Merck KGaA, Darmstadt, Germany

19 marketed · 22 in Phase 3

Quick facts

Founded1850

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Merck KGaA, Darmstadt, Germany

What are Merck KGaA, Darmstadt, Germany's marketed drugs?

Top marketed products include Biltricide®, Colposeptine, Efalizumab (Raptiva), Gabapentin/B-complex, GnRH antagonist, GONAL-f®.

What is Merck KGaA, Darmstadt, Germany's pipeline?

Merck KGaA, Darmstadt, Germany has 22 drugs in Phase 3, 11 in Phase 2, 26 in Phase 1. Late-stage candidates include cetuximab + cisplatin + vinorelbine, Cetuximab + concomitant boost radiotherapy, cisplatin + vinorelbine, COL-1620.

When was Merck KGaA, Darmstadt, Germany founded?

Merck KGaA, Darmstadt, Germany was founded in 1850.

How many employees does Merck KGaA, Darmstadt, Germany have?

Merck KGaA, Darmstadt, Germany has approximately 56,000 employees.

Related